Patents by Inventor Kimberley Anne Dellow

Kimberley Anne Dellow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gp130 lacking the transmembrane domain
    Patent number: 6380160
    Abstract: A novel splice-variant of gp130 is disclosed, together with the DNA sequence coding for it, pharmaceutical compositions comprising it and its use in ensuring the correct development of pre-implantation embryos.
    Type: Grant
    Filed: May 17, 1999
    Date of Patent: April 30, 2002
    Assignee: Applied Research Systems ARS Holding NV.
    Inventors: Andrew Sharkey, Stephen Kevin Smith, Kimberley Anne Dellow
  • Human SCF, a splice variant thereof, its pharmaceutical use
    Patent number: 6177556
    Abstract: SCF which includes the following C-terminal sequence: Glu Ile Cys Ser Leu Leu Ile Gly Leu Thr Ala Tyr Lys Glu Leu Ser Leu Pro Lys Arg Lys Glu Thr Cys Arg Ala Ile Gln His Pro Arg Lys Asp or a C-terminal sequence which is substantially homologous thereto and its use in medicine, particularly in ensuring the correct development of pre-implantation embryos.
    Type: Grant
    Filed: July 31, 1997
    Date of Patent: January 23, 2001
    Assignee: Applied Research Systems ARS Holdings N.V.
    Inventors: Andrew Mark Sharkey, Stephen Kevin Smith, Kimberley Anne Dellow
  • GP 130 lacking the transmembrane domain
    Patent number: 5965724
    Abstract: A novel splice-variant of gp 130 is disclosed, together with DNA sequence coding for it, pharmaceutical formulations comprising it, and its use ensuring the correct development of pre-implantation embryos.
    Type: Grant
    Filed: March 19, 1997
    Date of Patent: October 12, 1999
    Assignee: Applied Research Systems ARS Holding N.V.
    Inventors: Andrew Sharkey, Stephen Kevin Smith, Kimberley Anne Dellow